Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Rotavirus Vaccine Market Growth 2022-2028

  • LP 4809321
  • 73 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Rotavirus Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Human Rotavirus Vaccine market size is USD million in 2022 from USD 6606.9 million in 2021, with a change of % between 2021 and 2022. The global Human Rotavirus Vaccine market size will reach USD 10250 million in 2028, growing at a CAGR of 6.5% over the analysis period.

The United States Human Rotavirus Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Rotavirus Vaccine market, reaching US$ million by the year 2028. As for the Europe Human Rotavirus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Rotavirus Vaccine players cover Bharat Biotech, Merck, GlaxoSmithKline, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals & Clinics

Academic And Research

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bharat Biotech

Merck

GlaxoSmithKline

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Rotavirus Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Rotavirus Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Rotavirus Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Human Rotavirus Vaccine Segment by Type

2.2.1 Rotarix

2.2.2 RotaTeq

2.2.3 Rotavac

2.2.4 Rotavin-M1

2.2.5 Lanzhou lamb

2.2.6 Others

2.3 Human Rotavirus Vaccine Sales by Type

2.3.1 Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Human Rotavirus Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Rotavirus Vaccine Sale Price by Type (2017-2022)

2.4 Human Rotavirus Vaccine Segment by Application

2.4.1 Hospitals & Clinics

2.4.2 Academic And Research

2.4.3 Others

2.5 Human Rotavirus Vaccine Sales by Application

2.5.1 Global Human Rotavirus Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Human Rotavirus Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Rotavirus Vaccine Sale Price by Application (2017-2022)

3 Global Human Rotavirus Vaccine by Company

3.1 Global Human Rotavirus Vaccine Breakdown Data by Company

3.1.1 Global Human Rotavirus Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Human Rotavirus Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Human Rotavirus Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Human Rotavirus Vaccine Revenue by Company (2020-2022)

3.2.2 Global Human Rotavirus Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Human Rotavirus Vaccine Sale Price by Company

3.4 Key Manufacturers Human Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Rotavirus Vaccine Product Location Distribution

3.4.2 Players Human Rotavirus Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Rotavirus Vaccine by Geographic Region

4.1 World Historic Human Rotavirus Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Rotavirus Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Rotavirus Vaccine Annual Revenue by Geographic Region

4.2 World Historic Human Rotavirus Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Human Rotavirus Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Rotavirus Vaccine Annual Revenue by Country/Region

4.3 Americas Human Rotavirus Vaccine Sales Growth

4.4 APAC Human Rotavirus Vaccine Sales Growth

4.5 Europe Human Rotavirus Vaccine Sales Growth

4.6 Middle East & Africa Human Rotavirus Vaccine Sales Growth

5 Americas

5.1 Americas Human Rotavirus Vaccine Sales by Country

5.1.1 Americas Human Rotavirus Vaccine Sales by Country (2017-2022)

5.1.2 Americas Human Rotavirus Vaccine Revenue by Country (2017-2022)

5.2 Americas Human Rotavirus Vaccine Sales by Type

5.3 Americas Human Rotavirus Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Rotavirus Vaccine Sales by Region

6.1.1 APAC Human Rotavirus Vaccine Sales by Region (2017-2022)

6.1.2 APAC Human Rotavirus Vaccine Revenue by Region (2017-2022)

6.2 APAC Human Rotavirus Vaccine Sales by Type

6.3 APAC Human Rotavirus Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Rotavirus Vaccine by Country

7.1.1 Europe Human Rotavirus Vaccine Sales by Country (2017-2022)

7.1.2 Europe Human Rotavirus Vaccine Revenue by Country (2017-2022)

7.2 Europe Human Rotavirus Vaccine Sales by Type

7.3 Europe Human Rotavirus Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Rotavirus Vaccine by Country

8.1.1 Middle East & Africa Human Rotavirus Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Rotavirus Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Rotavirus Vaccine Sales by Type

8.3 Middle East & Africa Human Rotavirus Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine

10.3 Manufacturing Process Analysis of Human Rotavirus Vaccine

10.4 Industry Chain Structure of Human Rotavirus Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Rotavirus Vaccine Distributors

11.3 Human Rotavirus Vaccine Customer

12 World Forecast Review for Human Rotavirus Vaccine by Geographic Region

12.1 Global Human Rotavirus Vaccine Market Size Forecast by Region

12.1.1 Global Human Rotavirus Vaccine Forecast by Region (2023-2028)

12.1.2 Global Human Rotavirus Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Rotavirus Vaccine Forecast by Type

12.7 Global Human Rotavirus Vaccine Forecast by Application

13 Key Players Analysis

13.1 Bharat Biotech

13.1.1 Bharat Biotech Company Information

13.1.2 Bharat Biotech Human Rotavirus Vaccine Product Offered

13.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bharat Biotech Main Business Overview

13.1.5 Bharat Biotech Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Human Rotavirus Vaccine Product Offered

13.2.3 Merck Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Human Rotavirus Vaccine Product Offered

13.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Rotavirus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rotarix

Table 4. Major Players of RotaTeq

Table 5. Major Players of Rotavac

Table 6. Major Players of Rotavin-M1

Table 7. Major Players of Lanzhou lamb

Table 8. Major Players of Others

Table 9. Global Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 10. Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 11. Global Human Rotavirus Vaccine Revenue by Type (2017-2022) & ($ million)

Table 12. Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2022)

Table 13. Global Human Rotavirus Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 15. Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 16. Global Human Rotavirus Vaccine Revenue by Application (2017-2022)

Table 17. Global Human Rotavirus Vaccine Revenue Market Share by Application (2017-2022)

Table 18. Global Human Rotavirus Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Human Rotavirus Vaccine Sales by Company (2020-2022) & (K Units)

Table 20. Global Human Rotavirus Vaccine Sales Market Share by Company (2020-2022)

Table 21. Global Human Rotavirus Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Human Rotavirus Vaccine Revenue Market Share by Company (2020-2022)

Table 23. Global Human Rotavirus Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Human Rotavirus Vaccine Producing Area Distribution and Sales Area

Table 25. Players Human Rotavirus Vaccine Products Offered

Table 26. Human Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Human Rotavirus Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Human Rotavirus Vaccine Sales Market Share Geographic Region (2017-2022)

Table 31. Global Human Rotavirus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Human Rotavirus Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Human Rotavirus Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Human Rotavirus Vaccine Sales Market Share by Country/Region (2017-2022)

Table 35. Global Human Rotavirus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Human Rotavirus Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 38. Americas Human Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 39. Americas Human Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Human Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 41. Americas Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 42. Americas Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 43. Americas Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 44. Americas Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 45. APAC Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)

Table 46. APAC Human Rotavirus Vaccine Sales Market Share by Region (2017-2022)

Table 47. APAC Human Rotavirus Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Human Rotavirus Vaccine Revenue Market Share by Region (2017-2022)

Table 49. APAC Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 50. APAC Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 51. APAC Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 52. APAC Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 53. Europe Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 54. Europe Human Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 55. Europe Human Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 57. Europe Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 58. Europe Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 59. Europe Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 60. Europe Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Human Rotavirus Vaccine

Table 70. Key Market Challenges & Risks of Human Rotavirus Vaccine

Table 71. Key Industry Trends of Human Rotavirus Vaccine

Table 72. Human Rotavirus Vaccine Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Human Rotavirus Vaccine Distributors List

Table 75. Human Rotavirus Vaccine Customer List

Table 76. Global Human Rotavirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Human Rotavirus Vaccine Sales Market Forecast by Region

Table 78. Global Human Rotavirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Human Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Human Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Human Rotavirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Human Rotavirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Human Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Human Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Human Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Human Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Human Rotavirus Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Human Rotavirus Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Human Rotavirus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Human Rotavirus Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Human Rotavirus Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Human Rotavirus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 96. Bharat Biotech Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. Bharat Biotech Human Rotavirus Vaccine Product Offered

Table 98. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Bharat Biotech Main Business

Table 100. Bharat Biotech Latest Developments

Table 101. Merck Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Merck Human Rotavirus Vaccine Product Offered

Table 103. Merck Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Merck Main Business

Table 105. Merck Latest Developments

Table 106. GlaxoSmithKline Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. GlaxoSmithKline Human Rotavirus Vaccine Product Offered

Table 108. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. GlaxoSmithKline Main Business

Table 110. GlaxoSmithKline Latest Developments

List of Figures

Figure 1. Picture of Human Rotavirus Vaccine

Figure 2. Human Rotavirus Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Rotavirus Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Rotavirus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Rotavirus Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rotarix

Figure 10. Product Picture of RotaTeq

Figure 11. Product Picture of Rotavac

Figure 12. Product Picture of Rotavin-M1

Figure 13. Product Picture of Lanzhou lamb

Figure 14. Product Picture of Others

Figure 15. Global Human Rotavirus Vaccine Sales Market Share by Type in 2021

Figure 16. Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2022)

Figure 17. Human Rotavirus Vaccine Consumed in Hospitals & Clinics

Figure 18. Global Human Rotavirus Vaccine Market: Hospitals & Clinics (2017-2022) & (K Units)

Figure 19. Human Rotavirus Vaccine Consumed in Academic And Research

Figure 20. Global Human Rotavirus Vaccine Market: Academic And Research (2017-2022) & (K Units)

Figure 21. Human Rotavirus Vaccine Consumed in Others

Figure 22. Global Human Rotavirus Vaccine Market: Others (2017-2022) & (K Units)

Figure 23. Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Figure 24. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2021

Figure 25. Human Rotavirus Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Human Rotavirus Vaccine Revenue Market Share by Company in 2021

Figure 27. Global Human Rotavirus Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Human Rotavirus Vaccine Revenue Market Share by Geographic Region in 2021

Figure 29. Global Human Rotavirus Vaccine Sales Market Share by Region (2017-2022)

Figure 30. Global Human Rotavirus Vaccine Revenue Market Share by Country/Region in 2021

Figure 31. Americas Human Rotavirus Vaccine Sales 2017-2022 (K Units)

Figure 32. Americas Human Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. APAC Human Rotavirus Vaccine Sales 2017-2022 (K Units)

Figure 34. APAC Human Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Europe Human Rotavirus Vaccine Sales 2017-2022 (K Units)

Figure 36. Europe Human Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Human Rotavirus Vaccine Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Human Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 39. Americas Human Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 40. Americas Human Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 41. United States Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Human Rotavirus Vaccine Sales Market Share by Region in 2021

Figure 46. APAC Human Rotavirus Vaccine Revenue Market Share by Regions in 2021

Figure 47. China Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Human Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 54. Europe Human Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 55. Germany Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 62. Egypt Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Human Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2021

Figure 68. Manufacturing Process Analysis of Human Rotavirus Vaccine

Figure 69. Industry Chain Structure of Human Rotavirus Vaccine

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390